Wed, Oct 22, 2014, 6:02 AM EDT - U.S. Markets open in 3 hrs 28 mins


% | $
Quotes you view appear here for quick access.

Celgene Corp. (CELG) Message Board

  • padakri padakri Dec 28, 2005 9:31 PM Flag

    WSJ talks about estimate changes

    Estimates are being revised even at Morgan Stanley, I am sure the estimates and the price targets will be revised too. :-)

    "On a monthly basis, Revlimid is priced at about the same as Velcade, according to Sapna Srivastava, biotechnology analyst at Morgan Stanley who covers the company. Dr. Srivastava said Celgene priced Revlimid much higher than she had expected and so she was predicting eventual sales in excess of the $1 billion she had previously estimated."

94.97+2.97(+3.23%)Oct 21 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.